The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Long-Term Results of Treatment of 283 Patients with Lung and Bone Metastases from Differentiated Thyroid Carcinoma
Abstract
We assessed the results of treatment in 283 patients with lung or bone metastases from differentiated thyroid carcinoma who were followed for up to 40 yr (median, 44 months) after the discovery of the metastases. The survival rates from the time of discovery of the metastases were 53% at 5 yr, 38% at 10 yr, and 30% at 15 yr; 156 patients died. Multivariate analysis revealed that only 4 variables had an independent prognostic significance for survival. They were extensive metastases, older age at discovery of the metastases, absence of radioiodine uptake by the metastases, and moderately differentiated follicular cell type. The site of metastases (lung or bone) was not a prognostic factor for survival after treatment of metastatic disease. Remission was achieved in 79 patients after metastases were found. The only predictive factor for 5-yr disease-free survival after treatment of metastases was the initial extent of disease. Our results suggest that the aim of management should be to detect and treat metastases in patients with thyroid cancer as early as possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
Tubiana, M., Schlumberger, M., Rougier, P., Laplanche, A., Benhamou, E., Gardet, P., Caillou, B., Travagli, J.-P., & Parmentier, C. (1985) · Cancer · doi:10.1002/1097-0142(19850215)55:4<794::aid-cncr2820550418>3.0.co;2-z · Cited by 573
Self-citationRelation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid Cancer
Maxon, H. R., Thomas, S. R., Hertzberg, V. S., Kereiakes, J. G., Chen, I.-W., Sperling, M. I., & Saenger, E. L. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310203091601 · Cited by 503
External radiotherapy in thyroid cancers
Tubiana, M., Haddad, E., Schlumberger, M. J., Hill, C., Rougier, P. R., & Sarrazin, D. (1985) · Cancer · doi:10.1002/1097-0142(19850501)55:9+<2062::aid-cncr2820551406>3.0.co;2-o · Cited by 225
Ashcraft, M. W., & Van Herle, A. J. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90368-5 · Cited by 180
Beierwaltes, W. H., Nishiyama, R. H., Thompson, N. W., Copp, J., & Kubo, A. (1982) · PubMed · Cited by 171
Leeper, R. D. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-6-1143 · Cited by 144
Schlumberger, M. J., Charbord, P., Fragu, P., Lumbroso, J., Parmentier, C., & Tubiana, M. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-513 · Cited by 128
Self-citation
Cited by
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
Mazzaferri, E. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1447 · Cited by 1,396
Sherma, S. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12488-9 · Cited by 925
Gilliland, F. D., Hunt, W. C., Morris, D. M., & Key, C. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<564::aid-cncr20>3.0.co;2-0 · Cited by 803
Mazzaferri, E. L., Robbins, R. J., Spencer, C. A., Braverman, L. E., Pacini, F., Wartofsky, L., Haugen, B. R., Sherman, S. I., Cooper, D. S., Braunstein, G. D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021702 · Cited by 654
Hay, I. D. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30310-4 · Cited by 634
Metadata
- Authors
- MARTIN, S., MAURICE, T., VATHAIRE, F. D., CATHERINE, H., GARDET, P., TRAVAGLI, J.-P., FRAGU, P., LUMBROSO, J., CAILLOU, B., & PARMENTIER, C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1986-10
- Volume
- 63
- Issue
- 4
- Pages
- 960-967
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2028278716
- Cited by
- 552
- References
- 8
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.